PAAB Resource Appendix

Fair balance in Small Space Ads

Indication placement

Case 10: Multi-frame banner ad with indication across two frames.

Not acceptable

It isn't clear to the reader that the indication continues on to the second frame. All relevant boundaries of patient selection from the Indication and Clinical Use section of the TMA aren't presented with, or prior to, the first set of marketing benefit claims as required per code section 2.10.1.

728 x 90 Frame 1 of 2 from a several frame banner ad (only front end portion presented below)




Case 11: Multi-frame banner ad with indication across two frames.

Not acceptable

It is now clear that the indication continues on to the second frame. However, we have not resolved the fact that all relevant boundaries of patient selection from the Indication and Clinical Use section of the TMA aren't presented with, or prior to, the first set of marketing benefit claims.

728 x 90 Frame 1 of 2 from a several frame banner ad (only front end portion presented below)




Case 12: Multi-frame banner ad with indication across two frames.

Acceptable

It is clear that the indication continues on to the second frame, and all relevant boundaries of patient selection from the Indication and Clinical Use section of the TMA are presented with, or prior to, the first set of marketing benefit claims.

728 x 90 Frame 1 of 2 from a several frame banner ad (only front end portion presented below)



All examples and drugs are fictitious for training purposes. These ads have been designed for desktop viewing.